Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127644362 | 12764436 | 2 | F | 20160615 | 20160915 | 20160920 | 20160926 | EXP | IT-MINISAL02-373807 | IT-TEVA-693070ACC | TEVA | 64.74 | YR | M | Y | 0.00000 | 20160926 | MD | IT | IT |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127644362 | 12764436 | 1 | PS | PARACETAMOL | ACETAMINOPHEN | 1 | Oral | 1 DF AS NECESSARY | U | 0 | 1 | DF | |||||||
| 127644362 | 12764436 | 2 | SS | BISOPROLOL HEMIFUMARATE | BISOPROLOL FUMARATE | 1 | Oral | 1 DOSAGE FORMS DAILY; | U | 0 | 1 | DF |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127644362 | 12764436 | 1 | Product used for unknown indication |
| 127644362 | 12764436 | 2 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127644362 | 12764436 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127644362 | 12764436 | Asthenia | |
| 127644362 | 12764436 | Hyperhidrosis | |
| 127644362 | 12764436 | Loss of consciousness | |
| 127644362 | 12764436 | Syncope | |
| 127644362 | 12764436 | Vision blurred |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |